Merit Medical Systems Inc. (MMSI) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Merit Medical Systems’s revenue went from $604M in fiscal 2016 to $1.5B in fiscal 2025, growth of about 10.8% a year.
Net income in fiscal 2025 was $128M, a net margin of 8.5%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $1.6B and net income $160M.
Free cash flow was $216M in fiscal 2025 and positive in 9 of the 10 years shown.
The diluted share count rose 35% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.5B | $1.4B | $1.3B | $1.2B | $1.1B | $964M | $995M | $883M | $728M | $604M |
| Gross profit | $796M | $738M | $643M | $584M | $519M | $485M | $401M | $432M | $395M | $326M | $265M |
| Operating income | $218M | $185M | $156M | $124M | $88M | $61M | -$2M | $15M | $59M | $33M | $35M |
| Net income | $160M | $128M | $120M | $94M | $75M | $48M | -$10M | $5M | $42M | $28M | $20M |
| EPS (diluted) | $2.67 | $2.13 | $2.03 | $1.62 | $1.29 | $0.84 | $-0.18 | $0.10 | $0.78 | $0.55 | $0.45 |
| R&D | $97M | $97M | $87M | $83M | $76M | $71M | $58M | $66M | $60M | $51M | $45M |
| Revenue growth | — | +11.8% | +7.9% | +9.2% | +7.1% | +11.5% | −3.1% | +12.7% | +21.3% | +20.5% | +11.4% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $274M | $297M | $221M | $145M | $114M | $147M | $165M | $78M | $87M | $63M | $54M |
| Capital spending | -$70M | -$82M | -$35M | -$34M | -$45M | -$28M | -$46M | -$78M | -$63M | -$39M | -$33M |
| Free cash flow | $204M | $216M | $186M | $111M | $69M | $119M | $119M | -$360000 | $23M | $24M | $21M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based pay | $45M | $43M | $28M | $21M | $18M | $16M | $14M | $9M | $6M | $4M | $3M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $446M | $377M | $587M | $58M | $68M | $57M | $44M | $67M | $32M | $19M |
| Debt | — | $822M | $795M | $891M | $269M | $315M | $435M | $524M | $395M | $278M | $324M |
| Equity | — | $1.6B | $1.4B | $1.2B | $1.1B | $1.0B | $959M | $950M | $933M | $676M | $498M |
| Total assets | — | $2.7B | $2.4B | $2.3B | $1.7B | $1.6B | $1.7B | $1.8B | $1.6B | $1.1B | $943M |
| Shares (diluted) | 60M | 60M | 59M | 58M | 58M | 57M | 55M | 56M | 54M | 50M | 45M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 49.4% | 48.7% | 47.4% | 46.4% | 45.1% | 45.2% | 41.6% | 43.5% | 44.7% | 44.8% | 43.9% |
| Operating margin | 13.5% | 12.2% | 11.5% | 9.9% | 7.6% | 5.7% | -0.2% | 1.6% | 6.6% | 4.5% | 5.8% |
| Net margin | 9.9% | 8.5% | 8.9% | 7.5% | 6.5% | 4.5% | -1.0% | 0.5% | 4.8% | 3.8% | 3.3% |
| FCF margin | 12.6% | 14.2% | 13.7% | 8.8% | 6.0% | 11.1% | 12.4% | -0.0% | 2.6% | 3.3% | 3.4% |
| ROIC | — | 5.8% | 5.8% | 5.0% | 5.6% | 4.0% | -0.1% | 0.8% | 3.8% | 2.7% | 3.4% |
| ROE | — | 8.1% | 8.7% | 7.8% | 6.5% | 4.7% | -1.0% | 0.6% | 4.5% | 4.1% | 4.0% |
Frequently asked questions
What is Merit Medical Systems’s annual revenue?
$1.5B in fiscal 2025 and $1.6B over the twelve months to September 30, 2026.
How much profit does Merit Medical Systems make?
Net income was $128M in fiscal 2025 (net margin 8.5%).
Is Merit Medical Systems’s revenue growing?
Yes: revenue rose 11.8% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.